para-Nitrosodiphenylamine.
D000284:Administration, Oral; D000814:Aniline Compounds / Q000633:toxicity*; D000818:Animals; D002273:Carcinogens / Q000633:toxicity*; D004159:Diphenylamine / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000633:toxicity*; D005260:Female; D006801:Humans; D008114:Liver Neoplasms, Experimental / Q000139:chemically induced*; D008297:Male; D051379:Mice; D008815:Mice, Inbred Strains; D009374:Neoplasms, Experimental / Q000139:chemically induced*; D009603:Nitroso Compounds / Q000008:administration & dosage / Q000633:toxicity*; D051381:Rats; D011916:Rats, Inbred F344; D012306:Risk
D000814:Aniline Compounds; D002273:Carcinogens; D009603:Nitroso Compounds; D004159:Diphenylamine; C023829:4-nitroso-N-phenylaniline